Opioid Addiction Treatment Programs
According to the CDC, opioid overdoses were involved in 68,630 deaths in 2020. Opioid misuse has been an increasingly important issue in recent years, and there are many health conditions associated with it. The opioid addiction treatment centers that Community Medical Services operate offer several medication options for those who struggle with opioids. With these medications, individuals with an addiction to opioids can learn long-term coping skills and eliminate withdrawal symptoms and cravings.
Your Recovery Starts Today
Medication Options
Community Medical Services provides medication-assisted treatment (MAT) for individuals with opioid or substance use disorders. MAT uses a holistic approach to treat the “whole patient.” This is done with the use of FDA-approved medications, individual counseling, and behavioral therapy. Medication helps to alleviate withdrawal and cravings, allowing the patient to focus on mental health issues and positive behavior changes.
There are 3 FDA-approved medications for opioid use disorder treatment: methadone, buprenorphine, and naltrexone. MAT tries to find the lowest possible dose of a medication that will relieve withdrawal symptoms for 24 hours. The medications used in MAT are administered at a stable dose. They do not have any adverse effects on an individual’s ability to live a healthy life.
Methadone
- Long-lasting, allows for daily dosing.
- Is a more affordable medication option.
- Alleviates withdrawal symptoms, prevents cravings, and blocks the euphoric effect of other opioids.
- No abstinence from opioids is required before starting treatment.
- Synthetic opioid that attaches to the opioid receptor in the brain.
- Full agonist that fully activates the opioid receptor.
Buprenorphine
(Suboxone® / Subutex® / Sublocade™ / Brixadi)
- Long-lasting, allows for daily dosing.
- Good control of cravings and withdrawal.
- Alleviates withdrawal symptoms, prevents cravings, and blocks the euphoric effect of other opioids.
- Synthetic opioid that attaches to the opioid receptor in the brain.
- Partial agonist that activates some of the opioid receptors.
Naltrexone
Vivitrol®
- Long-lasting injectable medication that is administered every 28 days.
- Long-lasting injectable medication that is administered every 28 days.
- Not recommended for pregnant women.
- Will not alleviate withdrawal symptoms.
- Antagonist that blocks all effects of the opioid receptor.
Choosing the right medication for you and your lifestyle is a decision made by you in collaboration with your medical provider
Connect with your counselor on our free Recovery Connect app!
Community Medical Services developed this revolutionary app to make it easier for patients to connect with counselors and get real, meaningful support in the moments that matter.
Other Opioid Treatment Programs
Counseling Treatment
We provide both individual and group counseling services to our patients. Using evidence-based practices, counselors help clients to develop healthy coping strategies, individualized to their needs. Together, clients and counselors work on problem solving skills to address substance use.
Pregnancy & Women’s Health Treatment
At CMS, we recognize the unique healthcare needs of our pregnant clients. This is where methadone or buprenorphine, along with evidence-based behavioral therapies works. It’s recommended by SAMHSA as the standard of care to treat opioid addictions in pregnant women. CMS coordinates with OBGYN and other medical providers to ensure the highest quality of care.
Peer Support
Peer Support Specialists at CMS are individuals with lived experience. They can understand the challenges of substance use and recovery. They bring their unique perspective for overcoming challenges and navigating the treatment system.
Correctional Treatment
At CMS we believe that all people, regardless of incarceration status, deserve fair and equitable healthcare. Incarcerated individuals are at a greater risk of struggling with substance use. Approximately 68% of people incarcerated meet the medical criteria for drug dependence.